Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
Clinical trial NCT02871297 · TERMINATED
Trial details
- NCT number
- NCT02871297
- Sponsor
- H. Lundbeck A/S
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-17
- Primary completion
- 2022-03-25
- Enrollment
- 662
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.